Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases

Toxins (Basel). 2015 May 19;7(5):1749-64. doi: 10.3390/toxins7051749.

Abstract

Autoimmune diseases are usually accompanied by tissue injury caused by autoantigen-specific T-cells. KV1.3 channels participate in modulating calcium signaling to induce T-cell proliferation, immune activation and cytokine production. Effector memory T (TEM)-cells, which play major roles in many autoimmune diseases, are controlled by blocking KV1.3 channels on the membrane. Toxins derived from animal venoms have been found to selectively target a variety of ion channels, including KV1.3. By blocking the KV1.3 channel, these toxins are able to suppress the activation and proliferation of TEM cells and may improve TEM cell-mediated autoimmune diseases, such as multiple sclerosis and type I diabetes mellitus.

Keywords: KV1.3 channel; autoimmune diseases; effector memory T-cell; toxins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology*
  • Humans
  • Immunologic Factors / pharmacology*
  • Immunologic Factors / therapeutic use
  • Kv1.3 Potassium Channel / antagonists & inhibitors*
  • Kv1.3 Potassium Channel / immunology
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology
  • Toxins, Biological / pharmacology*
  • Toxins, Biological / therapeutic use

Substances

  • Immunologic Factors
  • Kv1.3 Potassium Channel
  • Toxins, Biological